Detalhe da pesquisa
1.
Regulatory workshop on challenge strain development and GMP manufacture - A stakeholder meeting report.
Biologicals
; 85: 101746, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38309984
2.
Mutation of Influenza A Virus PA-X Decreases Pathogenicity in Chicken Embryos and Can Increase the Yield of Reassortant Candidate Vaccine Viruses.
J Virol
; 93(2)2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30381488
3.
Segment 2 from influenza A(H1N1) 2009 pandemic viruses confers temperature-sensitive haemagglutinin yield on candidate vaccine virus growth in eggs that can be epistatically complemented by PB2 701D.
J Gen Virol
; 100(7): 1079-1092, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31169484
4.
Assessing the stability-indicating properties of alternative potency assays for inactivated influenza vaccine.
Vaccine
; 41(32): 4639-4647, 2023 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37344260
5.
Vaccine-induced neutralizing antibody responses to seasonal influenza virus H1N1 strains are not enhanced during subsequent pandemic H1N1 infection.
Front Immunol
; 14: 1256094, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37691927
6.
Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study.
Front Immunol
; 14: 1155552, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37143658
7.
An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study.
Front Immunol
; 14: 1129765, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36926342
8.
Improved antigen yield in pandemic H1N1 (2009) candidate vaccine viruses with chimeric hemagglutinin molecules.
J Virol
; 85(12): 6086-90, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21490098
9.
Application of deglycosylation to SDS PAGE analysis improves calibration of influenza antigen standards.
Biologicals
; 40(1): 96-9, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22244521
10.
Development of an ELISA-Based Potency Assay for Inactivated Influenza Vaccines Using Cross-Reactive Nanobodies.
Vaccines (Basel)
; 10(9)2022 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36146550
11.
Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study.
Front Immunol
; 13: 909297, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35784305
12.
Characterization of the interaction between the influenza A virus polymerase subunit PB1 and the host nuclear import factor Ran-binding protein 5.
J Gen Virol
; 92(Pt 8): 1859-1869, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21562121
13.
Broad Reactivity Single Domain Antibodies against Influenza Virus and Their Applications to Vaccine Potency Testing and Immunotherapy.
Biomolecules
; 11(3)2021 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33802072
14.
Nanobodies mapped to cross-reactive and divergent epitopes on A(H7N9) influenza hemagglutinin using yeast display.
Sci Rep
; 11(1): 3126, 2021 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33542302
15.
Protective efficacy of a polyvalent influenza A DNA vaccine against both homologous (H1N1pdm09) and heterologous (H5N1) challenge in the ferret model.
Vaccine
; 39(34): 4903-4913, 2021 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33036805
16.
Assay Harmonization and Use of Biological Standards To Improve the Reproducibility of the Hemagglutination Inhibition Assay: a FLUCOP Collaborative Study.
mSphere
; 6(4): e0056721, 2021 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34319129
17.
Expansion of the 1st WHO international standard for antiserum to respiratory syncytial virus to include neutralisation titres against RSV subtype B: An international collaborative study.
Vaccine
; 38(4): 800-807, 2020 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31708177
18.
Biosafety risk assessment for production of candidate vaccine viruses to protect humans from zoonotic highly pathogenic avian influenza viruses.
Influenza Other Respir Viruses
; 14(2): 215-225, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31659871
19.
Protection From Influenza by Intramuscular Gene Vector Delivery of a Broadly Neutralizing Nanobody Does Not Depend on Antibody Dependent Cellular Cytotoxicity.
Front Immunol
; 11: 627, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32547534
20.
Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies.
Vaccines (Basel)
; 8(4)2020 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33182279